Back to Search
Start Over
Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1
- Source :
- BMC Molecular Biology, BMC molecular biology 9(30), (2008). doi:10.1186/1471-2199-9-30, BMC Molecular Biology, Vol 9, Iss 1, p 30 (2008), Digital.CSIC. Repositorio Institucional del CSIC, instname
- Publication Year :
- 2008
- Publisher :
- BioMed Central, 2008.
-
Abstract
- Contiene además dos ficheros adicionales: Supplementary figures y Vector construction and oligonucleotide sequences.<br />[Background] Overexpression of the human DYRK1A gene due to the presence of a third gene copy in trisomy 21 is thought to play a role in the pathogenesis of Down syndrome. The observation of gene dosage effects in transgenic mouse models implies that subtle changes in expression levels can affect the correct function of the DYRK1A gene product. We have therefore characterized the promoter of the human DYRK1A gene in order to study its transcriptional regulation<br />[Results] Transcription start sites of the human DYRK1A gene are distributed over 800 bp within a region previously identified as an unmethylated CpG island. We have identified a new alternative noncoding 5'-exon of the DYRK1A gene which is located 772 bp upstream of the previously described transcription start site. Transcription of the two splicing variants is controlled by non-overlapping promoter regions that can independently drive reporter gene expression. We found no evidence of cell- or tissue-specific promoter usage, but the two promoter regions differed in their activity and their regulation. The sequence upstream of exon 1A (promoter region A) induced about 10-fold higher reporter gene activity than the sequence upstream of exon 1B (promoter region B). Overexpression of the transcription factor E2F1 increased DYRK1A mRNA levels in Saos2 and Phoenix cells and enhanced the activity of promoter region B three- to fourfold.<br />[Conclusions] The identification of two alternatively spliced transcripts whose transcription is initiated from differentially regulated promoters regions indicates that the expression of the DYRK1A gene is subject to complex control mechanisms. The regulatory effect of E2F1 suggests that DYRK1A may play a role in cell cycle regulation or apoptosis.<br />This work was supported by grants from the Deutsche Forschungsgemeinschaft (Be 1967/2-1) and DAAD (Acciones integradas Hispano-Alemanas D/05/25692). EMV and JG were supported by the Spanish Ministry of Education grant BMC2003-05026.
- Subjects :
- Therapeutic gene modulation
lcsh:QH426-470
Sp1 Transcription Factor
DNA Mutational Analysis
Molecular Sequence Data
Biology
Protein Serine-Threonine Kinases
Gene dosage
Gene Expression Regulation, Enzymologic
DYRK1A Gene
Gene product
Genes, Reporter
Cell Line, Tumor
Humans
RNA, Messenger
lcsh:QH573-671
Cyclic AMP Response Element-Binding Protein
Promoter Regions, Genetic
Molecular Biology
Regulator gene
Sequence Deletion
Genetics
Regulation of gene expression
Reporter gene
Binding Sites
Base Sequence
lcsh:Cytology
Reverse Transcriptase Polymerase Chain Reaction
Colforsin
Promoter
Protein-Tyrosine Kinases
Chromatin
Up-Regulation
lcsh:Genetics
Alternative Splicing
Transcription Initiation Site
Databases, Nucleic Acid
E2F1 Transcription Factor
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 14712199
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- BMC Molecular Biology
- Accession number :
- edsair.doi.dedup.....224db46facc31a8f0317aaf202ab8703
- Full Text :
- https://doi.org/10.1186/1471-2199-9-30